BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 30591535)

  • 21. Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis.
    Dutta P; Funston W; Mossop H; Ryan V; Jones R; Forbes R; Sen S; Pearson J; Griffin SM; Smith JA; Ward C; Forrest IA; Simpson AJ
    Thorax; 2019 Apr; 74(4):346-353. PubMed ID: 30610155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis.
    Spencer KL; Kennedy MPT; Lummis KL; Ellames DAB; Snee M; Brunelli A; Franks K; Callister MEJ
    Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 30635294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Podiatry interventions to prevent falls in older people: a systematic review and meta-analysis.
    Wylie G; Torrens C; Campbell P; Frost H; Gordon AL; Menz HB; Skelton DA; Sullivan F; Witham MD; Morris J
    Age Ageing; 2019 May; 48(3):327-336. PubMed ID: 30615052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Risk in Subsolid Nodules in the National Lung Screening Trial.
    Hammer MM; Palazzo LL; Kong CY; Hunsaker AR
    Radiology; 2019 Nov; 293(2):441-448. PubMed ID: 31526256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial.
    Marcus MW; Duffy SW; Devaraj A; Green BA; Oudkerk M; Baldwin D; Field J
    Thorax; 2019 Aug; 74(8):761-767. PubMed ID: 31028232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives.
    Oudkerk M; Liu S; Heuvelmans MA; Walter JE; Field JK
    Nat Rev Clin Oncol; 2021 Mar; 18(3):135-151. PubMed ID: 33046839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
    de Koning HJ; van der Aalst CM; de Jong PA; Scholten ET; Nackaerts K; Heuvelmans MA; Lammers JJ; Weenink C; Yousaf-Khan U; Horeweg N; van 't Westeinde S; Prokop M; Mali WP; Mohamed Hoesein FAA; van Ooijen PMA; Aerts JGJV; den Bakker MA; Thunnissen E; Verschakelen J; Vliegenthart R; Walter JE; Ten Haaf K; Groen HJM; Oudkerk M
    N Engl J Med; 2020 Feb; 382(6):503-513. PubMed ID: 31995683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation.
    Duarte A; Corbett M; Melton H; Harden M; Palmer S; Soares M; Simmonds M
    Health Technol Assess; 2022 Dec; 26(49):1-184. PubMed ID: 36534989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining growth in small pulmonary nodules using volumetry: results from a "coffee-break" CT study and implications for current nodule management guidelines.
    Bartlett EC; Kemp SV; Rawal B; Devaraj A
    Eur Radiol; 2022 Mar; 32(3):1912-1920. PubMed ID: 34580748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep convolutional neural networks for multiplanar lung nodule detection: Improvement in small nodule identification.
    Zheng S; Cornelissen LJ; Cui X; Jing X; Veldhuis RNJ; Oudkerk M; van Ooijen PMA
    Med Phys; 2021 Feb; 48(2):733-744. PubMed ID: 33300162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The growth feature and its diagnostic value for benign and malignant pulmonary nodules met in routine clinical practice.
    Zhang R; Tian P; Qiu Z; Liang Y; Li W
    J Thorac Dis; 2020 May; 12(5):2019-2030. PubMed ID: 32642104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe.
    Veronesi G; Baldwin DR; Henschke CI; Ghislandi S; Iavicoli S; Oudkerk M; De Koning HJ; Shemesh J; Field JK; Zulueta JJ; Horgan D; Fiestas Navarrete L; Infante MV; Novellis P; Murray RL; Peled N; Rampinelli C; Rocco G; Rzyman W; Scagliotti GV; Tammemagi MC; Bertolaccini L; Triphuridet N; Yip R; Rossi A; Senan S; Ferrante G; Brain K; van der Aalst C; Bonomo L; Consonni D; Van Meerbeeck JP; Maisonneuve P; Novello S; Devaraj A; Saghir Z; Pelosi G
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32599792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of lung cancer screening in Europe: challenges and potential solutions: summary of a multidisciplinary roundtable discussion.
    Field JK; deKoning H; Oudkerk M; Anwar S; Mulshine J; Pastorino U; Eberhardt W; Prosch H
    ESMO Open; 2019; 4(5):e000577. PubMed ID: 31673428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of lung cancer screening at the national level: Polish example.
    Rzyman W; Szurowska E; Adamek M
    Transl Lung Cancer Res; 2019 May; 8(Suppl 1):S95-S105. PubMed ID: 31211110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
    Walter JE; Heuvelmans MA; Ten Haaf K; Vliegenthart R; van der Aalst CM; Yousaf-Khan U; van Ooijen PMA; Nackaerts K; Groen HJM; De Bock GH; de Koning HJ; Oudkerk M
    Thorax; 2019 Mar; 74(3):247-253. PubMed ID: 30591535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
    Walter JE; Heuvelmans MA; Bock GH; Yousaf-Khan U; Groen HJM; Aalst CMV; Nackaerts K; Ooijen PMAV; Koning HJ; Vliegenthart R; Oudkerk M
    Thorax; 2018 Aug; 73(8):741-747. PubMed ID: 29661918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer screening: making the transition from research to clinical practice.
    Grosu HB; Eapen GA; Jimenez CA; Morice RC; Ost D
    Curr Opin Pulm Med; 2012 Jul; 18(4):295-303. PubMed ID: 22617813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.
    Silva M; Pastorino U; Sverzellati N
    Clin Radiol; 2017 May; 72(5):389-400. PubMed ID: 28168954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.